Visceral Obesity, Metabolic Syndrome, and Esophageal Adenocarcinoma

Visceral Obesity and the Metabolic Syndrome

Hypoadiponectinemia: A Link between Visceral Obesity and Metabolic Syndrome

Metabolic syndrome (MetS) represents a combination of cardiometabolic risk factors, including visceral obesity, glucose intolerance or type 2 diabetes, elevated triglycerides, reduced HDL cholesterol, and hypertension. MetS is rapidly increasing in prevalence worldwide as a consequence of the "epidemic" obesity, with a considerable impact on the global incidence of cardiovascular disease and ty...

Visceral obesity: a "civilization syndrome".

The controversial question of the relationship between obesity and disease has been considerably clearer after the demonstration in several prospective, epidemiological studies that the subgroup of central, visceral obesity is particularly prone to develop cardiovascular disease, stroke, and non-insulin dependent diabetes mellitus. Visceral obesity is associated with multiple central endocrine ...

Obesity and Metabolic Syndrome

Obesity is a state of the body, when the amount of energy delivered from food exceeds its consumption by the body. The concept of metabolic syndrome (MS) is determined by the coexistence of the clinical condition with connects risk factors for cardiovascular disease of atherosclerotic character and type 2 diabetes. Metabolic syndrome consists of: increased waist circumference, fasting blood glu...

Obesity, Metabolic Syndrome, and Adipocytes

Obesity and metabolic syndromes are examples whereby excess energy consumption and energy flux disruptions are causative agents of increased fatness. Because other, as yet elucidated, cellular factors may be involved and because potential treatments of these metabolic problems involve systemic agents that are not adipose depot-specific in their actions, should we be thinking of adipose depot-sp...